Instem plc 54I.SG Stock
Instem plc Price Chart
Instem plc 54I.SG Financial and Trading Overview
Instem plc stock price | 9 EUR |
Previous Close | 6.95 EUR |
Open | 6.95 EUR |
Bid | 6.95 EUR x 0 |
Ask | 7.85 EUR x 0 |
Day's Range | 6.95 - 6.95 EUR |
52 Week Range | 6.2 - 9.05 EUR |
Volume | 0 EUR |
Avg. Volume | 0 EUR |
Market Cap | 168.49M EUR |
Beta (5Y Monthly) | 0.539846 |
PE Ratio (TTM) | 30.21739 |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
54I.SG Valuation Measures
Enterprise Value | 176.92M EUR |
Trailing P/E | 30.21739 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.861634 |
Price/Book (mrq) | 2.9574468 |
Enterprise Value/Revenue | 3.005 |
Enterprise Value/EBITDA | 20.187 |
Trading Information
Instem plc Stock Price History
Beta (5Y Monthly) | 0.539846 |
52-Week Change | -14.72% |
S&P500 52-Week Change | 20.43% |
52 Week High | 9.05 EUR |
52 Week Low | 6.2 EUR |
50-Day Moving Average | 6.78 EUR |
200-Day Moving Average | 6.95 EUR |
54I.SG Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 22.89M |
Float | 20.64M |
Short Ratio | N/A |
% Held by Insiders | 20.69% |
% Held by Institutions | 64.89% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.97% |
Operating Margin (ttm) | 10.99% |
Gross Margin | 41.45% |
EBITDA Margin | 14.88% |
Management Effectiveness
Return on Assets (ttm) | 4.39% |
Return on Equity (ttm) | 9.33% |
Income Statement
Revenue (ttm) | 58.88M EUR |
Revenue Per Share (ttm) | 2.61 EUR |
Quarterly Revenue Growth (yoy) | 19.40% |
Gross Profit (ttm) | N/A |
EBITDA | 8.76M EUR |
Net Income Avi to Common (ttm) | 4.7M EUR |
Diluted EPS (ttm) | 0.23 |
Quarterly Earnings Growth (yoy) | 420.60% |
Balance Sheet
Total Cash (mrq) | 13.96M EUR |
Total Cash Per Share (mrq) | 0.62 EUR |
Total Debt (mrq) | 1.31M EUR |
Total Debt/Equity (mrq) | 2.45 EUR |
Current Ratio (mrq) | 0.929 |
Book Value Per Share (mrq) | 2.35 |
Cash Flow Statement
Operating Cash Flow (ttm) | 7.87M EUR |
Levered Free Cash Flow (ttm) | 5.49M EUR |
Profile of Instem plc
Country | Germany |
State | N/A |
City | Stone |
Address | Diamond Way |
ZIP | ST15 0SD |
Phone | 44 17 8582 5600 |
Website | https://www.instem.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 500 |
Instem plc, together with its subsidiaries, provides information technology solutions and services to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Blur Clinical Annonymization; Logbook ELN, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a windows-based system for non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; KnowledgeScan Target Safety Assessment services; SENDTrial, a web based solution that can be accessed through a subscription; and Predict delivers computational models. Further, the company provides Sorcerer Colony Counter; sales and administrative support; training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; software solutions to extract intelligence from research and development related healthcare data; and holds intellectual property rights and investment. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.
Q&A For Instem plc Stock
What is a current 54I.SG stock price?
Instem plc 54I.SG stock price today per share is 9 EUR.
How to purchase Instem plc stock?
You can buy 54I.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Instem plc?
The stock symbol or ticker of Instem plc is 54I.SG.
Which industry does the Instem plc company belong to?
The Instem plc industry is Health Information Services.
How many shares does Instem plc have in circulation?
The max supply of Instem plc shares is 24.18M.
What is Instem plc Price to Earnings Ratio (PE Ratio)?
Instem plc PE Ratio is 0.00000000 now.
What was Instem plc earnings per share over the trailing 12 months (TTM)?
Instem plc EPS is 0 EUR over the trailing 12 months.
Which sector does the Instem plc company belong to?
The Instem plc sector is Healthcare.